Literature DB >> 8094772

Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.

K Matsumura1, I Nonaka, K P Campbell.   

Abstract

The absence of dystrophin causes Duchenne muscular dystrophy. Dystrophin is associated with a large complex of sarcolemmal glycoproteins which provides a linkage to the extracellular matrix component, laminin, and when dystrophin is absent all the dystrophin-associated proteins are much reduced. We report here that dystrophin-associated proteins have abnormally low expression in Fukuyama-type congenital muscular dystrophy (FCMD), despite near-normal expression of dystrophin. An abnormality of dystrophin-associated proteins in the sarcolemma seems to be a common denominator in the pathological processes leading to muscle cell necrosis in three forms of severe muscular dystrophy (Duchenne, Japanese Fukuyama-type, and north African Duchenne-like autosomal recessive).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094772     DOI: 10.1016/0140-6736(93)90279-p

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  Recent advances in muscular dystrophies and myopathies.

Authors:  J R Anderson
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

2.  Characterization and localization of a 77 kDa protein related to the dystrophin gene family.

Authors:  E Fabbrizio; U Nudel; G Hugon; A Robert; F Pons; D Mornet
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

Review 3.  Investigation of muscle disease.

Authors:  F L Mastaglia; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 4.  Clinical genetics in neurological disease.

Authors:  J C MacMillan; P S Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

Review 5.  Increasing complexity of the dystrophin-associated protein complex.

Authors:  J M Tinsley; D J Blake; R A Zuellig; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

6.  Congenital muscular dystrophy with severe retrocollis and mental retardation: a report of two siblings.

Authors:  L Nashef; B D Lake; A H Schapira
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

7.  Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

Authors:  K Matsumura; I Nonaka; F M Tomé; K Arahata; H Collin; F Leturcq; D Récan; J C Kaplan; M Fardeau; K P Campbell
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

8.  Refined mapping of a gene responsible for Fukuyama-type congenital muscular dystrophy: evidence for strong linkage disequilibrium.

Authors:  T Toda; S Ikegawa; K Okui; E Kondo; K Saito; Y Fukuyama; M Yoshioka; T Kumagai; K Suzumori; I Kanazawa
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

9.  Congenital muscular dystrophy. A study on the variability of morphological changes and dystrophin distribution in muscle biopsies.

Authors:  Q H Leyten; H J ter Laak; F J Gabreëls; W O Renier; K Renkawek; R C Sengers
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Authors:  Susan C Brown; Silvia Torelli; Martin Brockington; Yeliz Yuva; Cecilia Jimenez; Lucy Feng; Louise Anderson; Isabella Ugo; Stephan Kroger; Kate Bushby; Thomas Voit; Caroline Sewry; Francesco Muntoni
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.